Elucidating the Inhibitory Potential of Statins Against Oncogenic c-Met Tyrosine Kinase Through Computational and Cell-based Studies
No relation between the statins' inhibitory effect and the c-Met pathway on cancerous cells could be reported.
Authors
- Amir Shadboorestan (ORCID: https://orcid.org/0000-0002-5695-8934)
- Mohammad Reza Torabi (ORCID: https://orcid.org/0009-0004-9434-6471)
- Vahideh Montazeri
- Shima Aliebrahimi (ORCID: https://orcid.org/0000-0001-8745-0271)
- Leila Karami (ORCID: https://orcid.org/0000-0002-8897-4832)
- Seyed Nasser Ostad (ORCID: https://orcid.org/0000-0002-5476-8010)
- Elham Alizadeh (ORCID: https://orcid.org/0000-0002-4588-3244)
- Fahimeh Ghasemi (ORCID: https://orcid.org/0000-0001-9333-4699)
Institutions
- Isfahan University of Medical Sciences (IR)
- Tarbiat Modares University (IR)
- Kharazmi University (IR)
- Eastern Mediterranean University (CY)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Iranian journal of pharmaceutical research
- Published
- 2025-08-16
- DOI
- https://doi.org/10.5812/ijpr-158845
- Citations
- 1
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94